SCHEMBL5636005

SCHEMBL5636005

N#CC(=Cc1c(-c2ccc(Br)c(F)c2)[nH]c2ccccc12)S(=O)(=O)c1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.58
HPGD P15428 5/20 0.58
MAPT P10636 4/20 0.58
KMT2A Q03164 4/20 0.58
MEN1 O00255 3/20 0.58
PKM P14618 2/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
LMNA P02545 3/20 0.44
POLB P06746 2/20 0.43
NPSR1 Q6W5P4 1/20 0.43
SMN1; SMN2 Q16637 3/20 0.42
KDM4E B2RXH2 3/20 0.42
HSD17B10 Q99714 2/20 0.42
GAA P10253 1/20 0.42
ALPG P10696 1/20 0.42
ALOX15 P16050 1/20 0.42
ALOX12 P18054 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
IDO1 P14902 1/20 0.42
MAPK1 P28482 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5636002 1.00 ALDH1A1 (0.58) ALDH1A1HPGDMAPTKMT2AMEN1
SCHEMBL5636055 0.92 KMT2A (0.49) ALDH1A1HPGDMAPTKMT2AMEN1
SCHEMBL5636050 0.92 KMT2A (0.49) ALDH1A1HPGDMAPTKMT2AMEN1
SCHEMBL5637102 0.82 MAPT (0.51) ALDH1A1HPGDMAPTKMT2AMEN1
SCHEMBL5637099 0.82 MAPT (0.51) ALDH1A1HPGDMAPTKMT2AMEN1
SCHEMBL5635476 0.81 ALDH1A1 (0.65) ALDH1A1HPGDMAPTKMT2AMEN1
SCHEMBL5635478 0.81 ALDH1A1 (0.65) ALDH1A1HPGDMAPTKMT2AMEN1
SCHEMBL5636256 0.77 MAPT (0.60) ALDH1A1HPGDMAPTKMT2AMEN1
SCHEMBL5636258 0.77 MAPT (0.60) ALDH1A1HPGDMAPTKMT2AMEN1
SCHEMBL5636618 0.76 MAPT (0.56) ALDH1A1HPGDMAPTKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070010559-A1 Indole derivatives for use as chemical uncoupler NOVO NORDISK A/S (DK) 2007-01-11 US claimed
EP-1689710-A1 INDOLE DERIVATIVES FOR USE AS CHEMICAL UNCOUPLER NOVO NORDISK A/S (DK) 2006-08-16 EP claimed
WO-2005051908-A1 INDOLE DERIVATIVES FOR USE AS CHEMICAL UNCOUPLER NOVO NORDISK A/S (DK) 2005-06-09 WO claimed
US-20070010559-A1 Indole derivatives for use as chemical uncoupler NOVO NORDISK A/S (DK) 2007-01-11 US disclosed
EP-1689710-A1 INDOLE DERIVATIVES FOR USE AS CHEMICAL UNCOUPLER NOVO NORDISK A/S (DK) 2006-08-16 EP disclosed
WO-2005051908-A1 INDOLE DERIVATIVES FOR USE AS CHEMICAL UNCOUPLER NOVO NORDISK A/S (DK) 2005-06-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070010559-A1 Indole derivatives for use as chemical uncoupler GPR119, IDO2, IDO1 ALDH1A1 1400/4885HPGD 841/4885MAPT 4316/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.